Articles From: Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study to Insight Enterprises, Inc. to Report Fourth Quarter and Full-Year 2012 Financial Results on February 14, 2013


2013/5/14
Polyvalent Vaccine Design Stimulates Significant Antibody and T-Cell Responses with 100% Survival Against Multiple Families of Most Lethal Virus Known to Man BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study investment picks
2013/3/7
BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals Prices $15.1 Million Offering of Common Stock and Warrants investment picks
2013/4/18
Biotech recognized for VGX-3100, an innovative therapy for pre-cancers and cancers caused by HPV, now in phase II for cervical dysplasia BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013 investment picks
2013/3/18
BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals Reports 2012 Fourth Quarter and Year End Financial Results investment picks
2013/5/10
BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals Reports 2013 First Quarter Financial Results investment picks
2013/2/4
BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals to Present at BIO CEO & Investor Conference investment picks
2013/3/28
BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals to Present at BioCentury's "Future Leaders in the Biotech Industry" Conference investment picks
2013/2/27
BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals to Present at the Cowen & Company Health Care Conference investment picks
2013/4/18
Broadly targeted SynCon® H1N1 vaccine induces protective antibodies comparable to current seasonal vaccine against currently circulating influenza strain BLUE BELL, Pa.
Sign-up for Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study investment picks
2013/2/5
Company invites Main Street and Wall Street investors to attend interactive real-time virtual conference NEW YORK , Feb.
Sign-up for Inovio Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th investment picks
2013/5/1
http://media.marketwire.com/attachments/201006/7704_InphiLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1012887&ProfileId=051205&sourceType=1 SANTA CLARA, CA --
Sign-up for Inphi Corporation Announces First Quarter 2013 Results investment picks
2013/2/4
http://media.marketwire.com/attachments/201006/7704_InphiLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=981688&ProfileId=051205&sourceType=1 SANTA CLARA, CA --
Sign-up for Inphi Corporation Announces Fourth Quarter and Full Year 2012 Results investment picks
2013/2/1
http://media.marketwire.com/attachments/201006/7704_InphiLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=980804&ProfileId=051205&sourceType=1 SANTA CLARA, CA --
Sign-up for Inphi to Present at the Stifel Nicolaus Technology Conference investment picks
2013/2/5
http://media.marketwire.com/attachments/201006/7704_InphiLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=981747&ProfileId=051205&sourceType=1 SANTA CLARA, CA --
Sign-up for Inphi to Present on Next-Generation 100G Interconnects for Cloud and Data Center Applications at the Linley Tech Data Center Conference 2013 investment picks
2013/5/21
NORTHVALE, N.J. , May 21, 2013 /PRNewswire/ --   Inrad Optics, Inc. (OTCBB: INRD) has reported its consolidated financial results for the three months ended March 31, 2013 .
Sign-up for Inrad Optics, Inc. Announces First Quarter 2013 Financial Results investment picks
2013/4/3
NORTHVALE, N.J. , April 3, 2013 /PRNewswire/ -- Inrad Optics, Inc. (the "Company") (OTC Bulletin Board: INRD) has released its consolidated financial results for the year ended December 31, 2012 .
Sign-up for Inrad Optics, Inc. Announces FY 2012 Financial Results investment picks
2013/3/7
NORTHVALE, N.J. , March 7, 2013 /PRNewswire/ -- Optical component and crystalline device manufacturer Inrad Optics, Inc. (OTCBB: INRD) announced a combined work-force reduction of eight employees at its Northvale, NJ and Sarasota, FL production facilities effective March 1 , 2013.
Sign-up for Inrad Optics, Inc. Announces Reduction In Work-force investment picks
2013/5/17
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1018514&ProfileId=051205&sourceType=1 BALTIMORE, MD --
Sign-up for Inscor Inc. Is Poised to Help Relieve Municipal Distress investment picks
2013/3/28
http://media.marketwire.com/attachments/201303/138372_INSCOR.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1001715&ProfileId=051205&sourceType=1 LAS VEGAS, NV --
Sign-up for INSCOR, Inc. Announces the Addition of Mark Bolt to the Company's Board of Directors investment picks
2013/5/31
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1022280&ProfileId=051205&sourceType=1 BALTIMORE, MD --
Sign-up for INSCOR's Offerings Aid Wealthy Individuals investment picks
2013/5/1
Insert after first graph: If you plan on participating in the conference call please dial (888) 428-9480 a minimum of five minutes prior to start of the call and reference the 7630095 confirmation code.
Sign-up for INSERTING and REPLACING Globecomm Announces Date of Third Quarter Financial Results Conference Call/Webcast investment picks
2013/4/11
NEW YORK (MarketWatch) — The Los Angeles–area man who traded on confidential information provided by a former KPMG LLP partner at the center of a federal insider-trading probe is Bryan Shaw, his lawyer said.
Sign-up for Insider trader in KPMG case is identified investment picks
2013/4/8
According to our database of insider trading filings, several company insiders at Windstream WIN , a $4.8 billion market cap U.S. telecom and business services company, have been buying shares since the beginning of March.
Sign-up for Insiders are crazy about this telecom stock investment picks
2013/6/10
TEMPE, Ariz., June 10, 2013 (GLOBE NEWSWIRE) -- Insight Enterprises , Inc. (Nasdaq:NSIT) , a leading worldwide technology provider of hardware, software and service solutions, is pleased to announce that they have been accredited by the Better Business Bureau (BBB) in Chicago.
Sign-up for Insight Earns Better Business Bureau Accreditation investment picks
2013/2/18
TEMPE, Ariz., Feb.
Sign-up for Insight Enterprises to Present at Investor Conference investment picks
2013/4/19
TEMPE, Ariz., April 19, 2013 (GLOBE NEWSWIRE) -- Insight Enterprises, Inc. (Nasdaq:NSIT) (the "Company") today announced that Ken Lamneck, President and Chief Executive Officer is scheduled as a keynote speaker at the 2013 Global Technology Distribution Council Investor Conference at the Sheraton New York Times Square Hotel in New York City on May 2, 2013 at 10:15 a.m. Eastern time.
Sign-up for Insight Enterprises to Present at Investor Conference investment picks
2013/5/1
TEMPE, Ariz., May 1, 2013 (GLOBE NEWSWIRE) -- Insight Enterprises, Inc. (Nasdaq:NSIT) (the "Company") today reported results of operations for the quarter ended March 31, 2013.
Sign-up for Insight Enterprises, Inc. Reports First Quarter 2013 Results investment picks
2013/2/14
TEMPE, Ariz., Feb.
Sign-up for Insight Enterprises, Inc. Reports Fourth Quarter and Full Year 2012 Results investment picks
2013/4/18
TEMPE, Ariz., April 18, 2013 (GLOBE NEWSWIRE) -- Insight Enterprises, Inc. (Nasdaq:NSIT) (the "Company") today reported that net sales for the quarter ended March 31, 2013 are expected to be approximately $1.2 billion, representing a decrease of approximately 5% from the first quarter of 2012.
Sign-up for Insight Enterprises, Inc. Reports Preliminary First Quarter 2013 Results investment picks
2013/1/31
TEMPE, Ariz., Jan.
Sign-up for Insight Enterprises, Inc. to Report Fourth Quarter and Full-Year 2012 Financial Results on February 14, 2013 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study to Insight Enterprises, Inc. to Report Fourth Quarter and Full-Year 2012 Financial Results on February 14, 2013
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity